Form D · Biotechnology
Fleming Holding LLC
New York, NY · CIK 0002074285
Offering snapshot reported Jun 23, 2025 · SEC filing
- Reported sold
- $0 Indefinite offering
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 30, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 23, 2025 | Initial | $0 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-549616
Includes 20,000 shares of the Issuer's Class A Common Units issued as consideration in connection with the acquisition.
Source: Form D, filed Jun 23, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joep Bruins | Director |
| Charlie Li | Director, Executive |
| Quanxi Li | Executive |
| Robert Wolff | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
228 E 45 Th Street Rm 9 E
New York, NY, 10017
New York, NY, 10017